|
Cipla's manufacturing facility in Goa gets two observations in Form 483 from US FDA> |
|
Cipla's Goa unit completes USFDA inspection with two observations> |
|
Cipla consolidated net profit declines 56.97% in the December 2025 quarter> |
|
Cipla slides as Q3 PAT tanks 57% YoY to Rs 676 crore> |
|
Cipla Ltd slips for fifth straight session> |
|
Cipla Ltd leads losers in 'A' group> |
|
Cipla declare Quarterly Result> |
|
Pfizer signs supply and marketing agreement with Cipla> |
|
Cipla receives ESG rating of 66> |
|
Cipla Ltd spurts 0.37%, gains for fifth straight session> |